chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The date given was 24-Jun-2023 which is 30 days from the date the vaccine was received.; No adverse event; She stated the dose was administer past the beyond used by date.; Patient received expired Moderna Bivalent vaccine as first dose of primary series; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (She stated the dose was administer past the beyond used by date.), WRONG PRODUCT ADMINISTERED (Patient received expired Moderna Bivalent vaccine as first dose of primary series), PRODUCT STORAGE ERROR (The date given was 24-Jun-2023 which is 30 days from the date the vaccine was received.) and NO ADVERSE EVENT (No adverse event) in a 31-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7180B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 18-Jul-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 18-Jul-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (She stated the dose was administer past the beyond used by date.) and WRONG PRODUCT ADMINISTERED (Patient received expired Moderna Bivalent vaccine as first dose of primary series). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The date given was 24-Jun-2023 which is 30 days from the date the vaccine was received.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (She stated the dose was administer past the beyond used by date.), WRONG PRODUCT ADMINISTERED (Patient received expired Moderna Bivalent vaccine as first dose of primary series), PRODUCT STORAGE ERROR (The date given was 24-Jun-2023 which is 30 days from the date the vaccine was received.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (She stated the dose was administer past the beyond used by date.), WRONG PRODUCT ADMINISTERED (Patient received expired Moderna Bivalent vaccine as first dose of primary series) and PRODUCT STORAGE ERROR (The date given was 24-Jun-2023 which is 30 days from the date the vaccine was received.).    No concomitant medication was reported.  The date given was 24-Jun-2023 which is 30 days from the date the vaccine was received. The vaccine was received thawed. No treatment information was reported.
gave patient immunization,told her to wait for 15 minutes. After 5 minutes patient experienced dizziness and feeling light headed. i was talking to patient constantly to keep her alert as much as possible. Her eyes started to roll back slightly and I laid her flat on ground with support behind her head, The patient remained conscious. Took her pulse which was steady and regular, breathing on own without difficulty. 911 was called immediately. After about 2-3 minutes patient was becoming more responsive .Aftera few more minutes we placed patient on the chair, at which time the paramedics arrived. Patient has had past experiences of fainting due to body piercings or had problems as a child when she was immunized that was later revealed to me by her father. Patient had a flight or fright experience and after another 20 minutes left with her father and boyfriend
This spontaneous report as received from a physician and the office manager refers to unspecified number of patients of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored PNEUMOVAX 23 (lot # L019836, expiry date 24-MAR-2017, strength, dose, route and site of administration were not reported). NO adverse symptoms were reported. This is one of several cases received from the same reporter. Additional information has been requested.
Aches; fatigue; Chills; fever; dose received: 3/dose number = 3; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received third (booster) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 18Nov2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included unspecified allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication was not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 13Jan2021 (at the age of 25-years-old)  and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 03Feb2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. On 18Nov2021 at 17:00, the patient experienced aches, fatigue, chills and fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with diphenhydramine citrate, ibuprofen (IBUPROFEN PM). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events aches, fatigue, chills and fever were resolved on an unknown date in Nov2021.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I have just had three cases of bronchitis since my COVID-19 vaccination. I don?t seem to be able to get rid of a long-term productive cough. * also I was contacted in April by your service and did call back and leave my telephone number because I was having bronchitis issues and I never received a callback. I did give them my availability time and tried to call a few times and was unable to get a hold of anyone. I hope this information helps.
hot flashes- 1-2 months; muscle aches- ongoing; brain fog- ongoing; sever back pain~ 6 months sever ithcing with large raised red areas after-- this lasted months~5 months.
Initial unsolicited report received from a Nurse on 04-May-2015. A 54-years-old female patient had received a first dose of TYPHIM VI via intramuscular route in the left deltoid (batch number: K0330-1, expiry date: 18-Jul-2016) and first dose of YF VAX via intramuscular route in the left triceps (batch number: UI091AA, expiry date: 02-Jun-2016) on 01-May-2015. The patient did not have any illness at the time of vaccination. The patient pre-existing physician diagnosed allergies, birth defects, medical conditions included asthma and bronchitis. He also took ADVIE inhaler and MEDROL pack was administered three weeks prior to vaccination. Concomitant medications were not reported. On 01-May-2015, post vaccination, the patient experienced left upper arm redness and swelling to elbow. On 03-May-2015, the patient developed a rash on her waist, hips and under the bra line. The patient required Emergency Room/Doctor Visit. She took BENADRYL (Over The Counter) and was administered steroid intramuscularly as a corrective treatment. She was evaluated by a physician who prescribed MEDROL PACK. Laboratory investigations were not reported. At the time of this report, the outcome of the events was reported as unknown. Documents held by sender: none.
Numbness in hand; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. This is the first case out of two split cases.  An 85-year-old male patient received BNT162b2 (BNT162B2), on 24Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 84 years for covid-19 immunisation. The patient's relevant medical history included: "Blood pressure high" (unspecified if ongoing). Concomitant medication(s) included: AMLODIPINE taken for hypertension; TELMISARTAN; CARVEDILOL. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot number: EP6955), administration date: 22Mar2021, when the patient was 83-year-old, for COVID-19 Immunization; BNT162b2 (DOSE 1, SINGLE, Lot number: EP6955), administration date: 22Mar2021, when the patient was 83-year-old, for Covid-19 immunization; BNT162b2 (DOSE 2, SINGLE), administration date: 19Apr2021, when the patient was 83-year-old, for Covid-19 immunization; BNT162b2 (DOSE 2, SINGLE), administration date: 19Apr2021, when the patient was 83-year-old, for Covid-19 Immunization. The following information was reported: HYPOAESTHESIA (non-serious), outcome "not recovered", described as "Numbness in hand". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient took Pfizer Covid-19 vaccine and then got the virus this year and now got over that but had side effects from the virus. It kept on lingering. Side effects: first was numbness in hand and he cannot use his right hand at all because of the numbness. The patient had investigations as his doctor was looking at the antibodies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201304866 same product, different patient/event;US-PFIZER INC-202201304927 same product/event, different patients;
tested positive after the first dose; tested positive after the first dose; This is a spontaneous report from a Pfizer sponsored program from a contactable consumer. This consumer reported similar events for two patients. This is the first of two reports. A male patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at single dose on 25Jan2021 for COVID-19 immunisation. Medical history and concomitant medication were not reported. Caller was calling for her parents who tested positive after the first dose. Their first dose was last 25Jan. Caller was asking if they could take the second dose after they tested positive or they had to wait for a certain time before getting the second dose. COVID-19 test was positive on an unspecified date. The outcome of events was unknown.  The information about lot/batch number has been requested. ; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021209407 the same reporter, product and adverse events in different patients
Baseball size area of red, hot, swollen response with in hours of administration increased area of inflammation to grapefruit size. prompting trip to ER. PT DX'd with cellulitis injection site, ATB's RX'd
bilateral nocturnal leg cramps, four severe episodes, onset about 8 hrs after getting the vaccine.  He says four in one night +- severity unusual for him.
Approximately 6 months post vax, the pt's lips became swollen and his chin turned cyanotic. The pt was taken to the ER and given Benadryl and held for observation. Swelling reduced the following day, but the chin appeared bruised. MD thought it was a reaction to one of the vaccines.
Hospitalized 01/20/22; COVID-19 positive 01/20/2022; fully vaccinated. Discharge Provider: PRIVATE MD. Primary Care Provider: PRIVATE MD. Admission Date: 1/20/2022. Discharge Date: 1/22/2022. DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Ischemic stroke (HCC) [I63.9], Ischemic cerebrovascular accident (CVA) (HCC) [I63.9], COVID-19 virus infection [U07.1]. HOSPITAL COURSE: 66 yo female presented to the ER with the complaint of dizziness, nausea, and ataxia that started the day prior. Her head CT noted an acute infarct in the superior right MCA distribution. She additionally tested positive for Covid. She was admitted for further evaluation and management.  She was monitored on telemetry and had serial neurologic exams. A MRI was done noting a stroke with small petechial hemorrhages. Given this, Lovenox was held and neurology advised repeating a CT the following day. Over the course of her hospital stay her dizziness and ataxia resolved. Physical and occupational therapy has no concerns and feels she does not need outpatient therapy. Her repeat CT showed no worsening of her infarct or petechial hemorrhage. She will discharge home today in improved and stable condition.
I developed a high pitch ringing in the ears the morning after the vaccine.  It was noticed when I woke up.  I did have a low fever, high chills, and significant neck muscle "cramping" during the night when this reaction developed.  The ringing (Tinnitus) is pretty loud and bothersome.  The volume has not changed since the day after my vaccine shot (two weeks now).
never had AFib until recieve the 2 shots and booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, UNKNOWN LOT), for Covid-19 immunization; Bnt162b2 (DOSE 2, UNKNOWN LOT), for Covid-19 immunization. The following information was reported: ATRIAL FIBRILLATION (medically significant), outcome "unknown", described as "never had AFib until recieve the 2 shots and booster". Therapeutic measures were taken as a result of atrial fibrillation included abalition surgery. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
2-3 days following administration of PCV and DTaP in (R) lat thigh - had swelling, redness 5 cm. Now rash is over groin and trunk.
CHILD BEGAN JERKING AND STARING IMMEDIATELY FOLLOWING ADMINISTRATION OF VACCINES.  EPISODE LASTED APPROXIMATELY 30 SECONDS.  CHILD THEN VOMITED SMALL AMOUNT.  CHILD WAS EVALUATED BY DOCTOR.  NO TREATMENT.  CHILD RECOVERED AND RELEASED TO HOME.
R/O rhabdomyolysis. Orange urine with moderate blood, fever and painful (R) arm site of injection.
Patient started having nausea, lightheaded, heart pounding that went away and returned. Patient also reported HA.  Rapid Response was called and patient was discharged.
cough; felt cold; soreness in shoulders and back; soreness in shoulders and back; This is a spontaneous report from a contactable consumer via medical information team. A female patient of an unspecified age (reported as 78, no unit) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history included asthma. The patient had no concomitant medications. The patient took the first shot and she picked up a cough. The patient had a cough anyway because of asthma but seemed to have picked up an extra one. The patient felt cold most of the time. She has soreness in shoulders and back and would receive the second dose in February. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
At around 4am, I began experiencing pain inside my chest and abdomen areas. I felt like I wanted to throw up,  I was shaking to the point that I couldn't see anything clear in front of me despite my fever being only 100.4.  I was not able to hold a cup in my hands because I was shaking so much and the water was spilling all over. When I got up to go to use the bathroom, I fell once, and after I got up I had to hold onto the walls to walk there.  I was not able to eat for a day. I was sick for 5 days after that. Same symptoms after I received my 2nd and 3rd shots, also sick for 4-5 days.
Person was positive for COVID 19 on 3/29/21. 4 months after vaccine completed
Flu-like nasal symptoms; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like nasal symptoms) and FATIGUE (Fatigue) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 027A21A) for COVID-19 vaccination.     Concomitant products included ALLOPURINOL, CLOPIDOGREL, METFORMIN, AMLODIPINE, ATORVASTATIN and MIRTAZAPINE for an unknown indication.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like nasal symptoms) and FATIGUE (Fatigue). On 08-Apr-2021, INFLUENZA LIKE ILLNESS (Flu-like nasal symptoms) and FATIGUE (Fatigue) had resolved.        Action taken with mRNA-1273 in response to the events was not Applicable.  Treatment medications are not reported.   This case was linked to MOD-2021-073232 (Patient Link).
This spontaneous report as received from a nurse refers to an 8 months 30 days old male patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) Liquid PEDVAXHIB (injection, lot # K016965, exp. date: 20-JUL-2017)(dose, strength and route unspecified). No concomitant medications were reported. No adverse experiences have been reproted so far. THere were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected. no contact details were provided.
Rash to left thigh where injection site is at. No induration and no fever. Pt did no have any other symptoms. Advise to apply ice to site and give Benadryl every 6 hrs and Motrin every 6-8 hrs for two days
Bilateral leg rash with itching. Started the next morning. Prednisone 20mg.
C18.9 - Adenocarcinoma of colon  C19 - Malignant neoplasm of rectosigmoid junction
I started getting symptoms of postnasal drip, runny nose, sinus pressure, headache. Then I stared getting chills, body aches, and fever. I took 2 at home COVID-19 test and it was positive. I then went to an urgent care walk in clinic and brought in my results. I was prescribed Molnupiravir, albuterol, and cough medication. Those medications did not help right away. The coughing is the worse and was hard to breath. I finished the antiviral drug and now I do feel somewhat normal.
p/vax pt noted tingling/out break of herpes zoster; lesions appeared 8/8/99 or 8/7/99;
Shingles - pain/burning  started mid march, rash appeared a week later.  Blisters/lesions in C7 Dermatone upper right back, progressing to upper right and left arm, and upper back.
COAGULOPATHY, UNSPECIFIED TYPE 1/16/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Severe body aches; Chills; 102.7 F temp; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09April2021 at 10:30(at the age of 52-year-old) as a single dose for COVID-19 immunisation.  Medical history included fibromyalgia, osteoarthritis, degenerative disc disease, degenerative joint disease, asthma, depression. Concomitant medication included meloxicam (MELOXICAMUM), tizanidine hydrochloride (TIZANIDINE), pregabalin (LYRICA) and duloxetine hydrochloride (CYMBALTA) all started on unknown dates and for an unspecified indications. The patient was allergic to TRAZADONE, NAPROXENE. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 18March2021 at 10:30(at the age of 52-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021, the patient experienced severe body aches, chills, 102.7 F temp. Therapeutic measures were not taken as a result of the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic and emergency room/department or urgent care. The clinical outcome of the events severe body aches, chills, 102.7 F temp was not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected.
TROUBLE MOVING FINGERS; WRIST PAIN; FOREARM PAIN; .This spontaneous report received from a parent concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered at on 07-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 07-MAR-2021, the subject experienced trouble moving fingers. On 07-MAR-2021, the subject experienced wrist pain. On 07-MAR-2021, the subject experienced forearm pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the trouble moving fingers, wrist pain and forearm pain was not reported. This report was non-serious.
The very next day after getting a flu shot:  Complaints of nervous stomach and tightness in throat.   No history of anxiety issues.  Has been having anxiety attacks daily ever since, sometimes multiple times a day.  Varies from mild to severe where he has nervous stomach, fast heart rate, tightness in throat, and physically shaking.
Suspected vaccination failure; I got the flu after the shot; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure' in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced vaccination failure (serious criteria GSK medically significant) and influenza. On an unknown date, the outcome of the vaccination failure and influenza were unknown.   It was unknown if the reporter considered the vaccination failure and influenza to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at the vaccination was not reported.  The patient reported years ago when it was a live virus he/she got the flu after the shot but now it's a dead virus and took the flu shot every year now and had not had the flu. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation for flu were not provided.